News Daily News Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose L.A. McKeown December 01, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death Michael O'Riordan July 07, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC Yael L. Maxwell April 12, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short Shelley Wood January 31, 2023